Olga S. Lebedeva - Concepedia

Author

Olga S. Lebedeva

Also Known As

Lebedeva, Olga S., O. S Lebedeva, O. S. Lebedeva, O.S. Lebedeva, Olga Lebedeva, Olga S. Lebedeva, Olga Sergeevna Lebedeva, О. S. Lebedeva, О. С. Лебедева, О.С. Лебедева

Publications

603

Citations

H-Index

Concepts

All Affiliations

Federal Medical-Biological Agency Research Center of Neurology Vavilov Institute of General Genetics Lomonosov Moscow State University Institute of Molecular Genetics

About

Olga S. Lebedeva is an author at Federal Medical-Biological Agency specializing in medicine, neurodegenerative diseases, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	108
2	Cell Biology	3	3	85
3	Social Sciences	1	1	39
4	Immunology	1	1	23
5	Neurology	1	1	39

Olga S. Lebedeva

Publications

452

Citations

H-Index

Page 1

	Year	Citations
Manifestation of Huntington’s disease pathology in human induced pluripotent stem cell-derived neurons V. A. Vigont, S. A. Klyushnikov, Olga S. Lebedeva, Molecular Neurodegeneration	2016	151
Creation of a library of induced pluripotent stem cells from Parkinsonian patients Staffan Holmqvist, Šárka Lehtonen, Margarita Chumarina, npj Parkinson s Disease	2016	91
STIM2 Mediates Excessive Store-Operated Calcium Entry in Patient-Specific iPSC-Derived Neurons Modeling a Juvenile Form of Huntington's Disease V. A. Vigont, Dmitriy A. Grekhnev, Olga S. Lebedeva, Frontiers in Cell and Developmental Biology Neurodegenerative DiseasesMolecular NeuroscienceSignal TransductionHd PathogenesisHuntingtin Protein	2021	39
Mutations in the Parkinson’s Disease-Associated PARK2 Gene Are Accompanied by Imbalance in Programmed Cell Death Systems O. M. Lopacheva, Olga S. Lebedeva, E. Yu. Fedotova Acta Naturae GeneticsApoptosisCell DeathDisease Gene IdentificationSynaptic Signaling	2015	27
iPSC-derived cells lack immune tolerance to autologous NK-cells due to imbalance in ligands for activating and inhibitory NK-cell receptors Margarita E. Bogomiakova, Elizaveta K. Sekretova, Ksenia S. Anufrieva, Stem Cell Research & Therapy	2023	26
EGCG as an anti-SARS-CoV-2 agent: Preventive versus therapeutic potential against original and mutant virus Vladimir B. Tsvetkov, Anna M. Varizhuk, Liubov I. Kozlovskaya, Biochimie ImmunologyAntiviral Drug DevelopmentAntiviral TherapyVirologyAntiviral Drug	2021	23
The Transcriptional Changes of trim Genes Associated with Parkinson’s Disease on a Model of Human Induced Pluripotent Stem Cells Valentina V. Nenasheva, Irina Makarova, Olga S. Lebedeva, Molecular Neurobiology Stem Cell BiologyTranscriptional RegulationNeurodegenerative DiseasesInduced Pluripotent Stem CellMedicine	2016	19
Possibilities for Using Pluripotent Stem Cells for Restoring Damaged Eye Retinal Pigment Epithelium A. E. Kharitonov, A. V. Surdina, Olga S. Lebedeva, Acta Naturae	2018	12
Derivation of induced pluripotent stem cells line (RCPCMi007-A-1) with inactivation of the beta-2-microglobulin gene by CRISPR/Cas9 genome editing Margarita E. Bogomiakova, Elizaveta K. Sekretova, Artem V. Eremeev, Stem Cell Research	2021	12
The morphofunctional properties of induced pluripotent stem cells derived from human skin fibroblasts and differentiated to dopaminergic neurons Olga S. Lebedeva, Maria A. Lagarkova, Maria V. Vedunova, Neurochemical Journal	2013	11

Page 1